» Articles » PMID: 9288698

The Relationship of Bacterial Vaginosis, Candida and Trichomonas Infection to Symptomatic Vaginitis in Postmenopausal Women Attending a Vaginitis Clinic

Overview
Journal Maturitas
Specialty Geriatrics
Date 1997 Jul 1
PMID 9288698
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate the prevalence of bacterial vaginosis, Candida albicans, and Trichomonas vaginalis infections in a population of postmenopausal women with symptoms of vaginitis seen at a vaginitis clinic either as self-referred or clinician referred patients.

Methods: A cross-sectional study of 148 postmenopausal women (cases) and 1564 controls of reproductive age attending a vaginitis clinic. C. albicans and T. vaginalis infections were diagnosed by culture techniques. Bacterial vaginosis was diagnosed on the basis of clinical findings.

Results: Fifty-six (37.8%) postmenopausal women and 834 (53.3%) controls were diagnosed with T. vaginalis or C. albicans infection, or bacterial vaginosis, or mixed infection (odds ratio (OR) 0.53, 95% confidence interval (CI) 0.37-0.75). C. albicans and T. vaginalis infection were diagnosed in 34.1% (534/1564) and 1.92% (30/1564) of women of childbearing age and in 13.5% (20/148) and 10.8% of postmenopausal women, respectively. (P < 0.05 for both comparisons). The prevalence of bacterial vaginosis was similar between the two groups (14/148 in postmenopausal patients and 210/1564 in controls of reproductive age; P = 0.22).

Conclusions: Among postmenopausal women attending a vaginitis clinic, a defined diagnosis of bacterial vaginosis, C. albicans or T. vaginalis infection can be made in about one third of such patients. Concerning the two thirds of symptomatic women lacking such a microbiologic diagnosis, alternative causes (e.g., estrogen deficiency, nonanaerobic bacterial infections, local irritants or allergenes, and dermatologic conditions) need to be considered.

Citing Articles

Microbial Milieu and Antibiogram of Female Genital Infections in a Tertiary Health Facility in Nigeria.

Amadi S, Mkpe A, Awopeju A, Iwo-Amah R, Olobuah A Niger Med J. 2024; 63(5):348-355.

PMID: 38867752 PMC: 11165321.


The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection.

Harding A, Heaton N Cancers (Basel). 2022; 14(4).

PMID: 35205657 PMC: 8870346. DOI: 10.3390/cancers14040909.


Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence.

Pereira L, Correia A, da Silva Z, de Resende C, Brandao F, Almeida R Eur J Clin Microbiol Infect Dis. 2021; 40(8):1681-1693.

PMID: 33713006 PMC: 8295079. DOI: 10.1007/s10096-021-04199-1.


The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

dEnfert C, Kaune A, Alaban L, Chakraborty S, Cole N, Delavy M FEMS Microbiol Rev. 2020; 45(3).

PMID: 33232448 PMC: 8100220. DOI: 10.1093/femsre/fuaa060.


Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation.

McGovern A, Hogg M, Shields B, Sattar N, Holman R, Pearson E BMJ Open Diabetes Res Care. 2020; 8(1).

PMID: 32448787 PMC: 7252998. DOI: 10.1136/bmjdrc-2020-001238.